Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/22/2025

Management of Watery Diarrhea in Patients with Diabetes

Initial Assessment and Management

  • The American College of Physicians recommends assessing hydration status and providing appropriate fluid replacement in patients with watery diarrhea, with a goal of preventing dehydration 1, 2
  • A BRAT diet (Bananas, Rice, Applesauce, Toast) is recommended to help reduce stool frequency in patients with watery diarrhea 1

Pharmacological Management

  • Loperamide is recommended as the first-line treatment for slowing down watery diarrhea in patients with diabetes, with an initial dose of 4 mg followed by 2 mg after each loose stool, not exceeding 16 mg daily, as suggested by the National Comprehensive Cancer Network 1
  • Diphenoxylate/atropine may be considered as an alternative option for patients with watery diarrhea, at a dose of 1-2 tablets PO every 6 hours as needed, maximum 8 tablets/day, according to the National Comprehensive Cancer Network 1
  • Anticholinergic agents, such as hyoscyamine and atropine, may be used for persistent symptoms of watery diarrhea, with dosages of 0.125 mg PO/ODT/SL every 4 hours PRN and 0.5-1 mg subcutaneous, IM, IV, or SL every 4-6 hours as needed, respectively, as recommended by the National Comprehensive Cancer Network 1

Hydration Therapy

  • Oral hydration and electrolyte replacement are recommended for patients with watery diarrhea, with a goal of preventing dehydration, as suggested by the National Comprehensive Cancer Network and the Annals of Oncology 1, 2
  • Oral rehydration solutions (ORS) containing 65-70 mEq/L sodium and 75-90 mmol/L glucose are recommended for mild to moderate dehydration, according to the Annals of Oncology 2
  • IV fluids may be necessary for severe dehydration or if patients are unable to tolerate oral fluids, as recommended by the Annals of Oncology and Clinical Infectious Diseases 2, 3
  • Ongoing fluid losses should be replaced, with approximately 10 mL/kg for each watery stool, as suggested by the MMWR Recommendations and Reports 4, 5

Treatment Escalation for Persistent Symptoms

  • For persistent Grade 2-4 diarrhea, octreotide may be considered at a dose of 100-500 mcg/day subcutaneous or IV, every 8 hours or by continuous infusion, as recommended by the National Comprehensive Cancer Network and the Annals of Oncology 1, 6

Cautions and Contraindications

  • Antimotility drugs like loperamide should be avoided in cases of bloody diarrhea, fever with diarrhea, or suspected toxic megacolon, as recommended by the Journal of Travel Medicine and Clinical Infectious Diseases 3, 7